CNBC

Iran war is a 'catastrophe,' G7 ministers warn — but there's little they can do to stop it cnbc.com/2026/03/26/g7-…

Electronic warfare in the Persian Gulf: How GPS interference is disrupting the Middle East cnbc.com/2026/03/26/how…

CNBC Daily Open: Talking in circles on Iran cnbc.com/2026/03/26/cnb…

Trump wants to squeeze Iran into peace talks with more troops — but it may backfire, analysts say cnbc.com/2026/03/26/tru…

European markets head for lower open amid Iran peace talks uncertainty cnbc.com/2026/03/26/eur…

The oil market is in 'backwardation,' analysts say. Here’s what that means for energy prices cnbc.com/2026/03/26/mar…

'Grin and bear it': How investors are navigating the Trump-Iran market whiplash cnbc.com/2026/03/26/us-…

White House posts cryptic videos, deletes one, fueling speculation online cnbc.com/2026/03/26/tru…

Trump says Justices Barrett, Gorsuch ‘sicken me’ after Supreme Court tariff ruling cnbc.com/2026/03/26/tru…

CNBC Daily Open: Iran rejects ceasefire, but reviews peace plan cnbc.com/2026/03/26/cnb…

Oil prices rise as Iran rejects direct U.S. talks despite proposal review cnbc.com/2026/03/26/oil…

Inside India newsletter: Ikea has high hopes for the country as it stares at a global slowdown cnbc.com/2026/03/26/ike…

Asia markets set to fall as Iran rules out direct U.S. talks despite reviewing proposal cnbc.com/2026/03/26/asi…

Thursday's big stock stories: What’s likely to move the market in the next trading session cnbc.com/2026/03/25/thu…

Rep. Seth Moulton bans staff from using prediction markets like Kalshi, Polymarket cnbc.com/2026/03/25/set…

Jim Cramer says Wall Street is in denial about the market cnbc.com/2026/03/25/jim…

Stock futures are little changed as traders monitor U.S.-Iran war developments: Live updates cnbc.com/2026/03/25/sto…

Republicans block Democratic push for Trump Jr. subpoena cnbc.com/2026/03/25/don…

Stocks making the biggest moves after hours: Worthington Steel, Karman, MillerKnoll and more cnbc.com/2026/03/25/sto…

The cost of GLP-1 drugs is falling, and pill versions are hitting the U.S. market. For restaurant chains and snacking giants, higher adoption of weight loss and diabetes treatments poses a threat to their sales — or an opportunity. Full story: cnb.cx/3PmQY2F